Status:

NOT_YET_RECRUITING

Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer Using Durvalumab-680LT and Nivolumab-800CW

Lead Sponsor:

University Medical Center Groningen

Collaborating Sponsors:

Martini Hospital Groningen

Conditions:

Esophageal Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE1

Brief Summary

Radiation and chemotherapy can shrink the tumor. For certain types of cancer, immunotherapy is added to further reduce the tumor size. Immunotherapy works for some patients and can sometimes keep the ...

Eligibility Criteria

Inclusion

  • Lesion suspected for locally advanced EC (cT1b-4a N0-3 M0);
  • Indication for neoadjuvant therapy or definitive chemo-radiation therapy;
  • Age ≥ 18 years;
  • Written informed consent.

Exclusion

  • Medical or psychiatric conditions that compromise the patient's ability to give informed consent according to treating medical physician;
  • Concurrent uncontrolled medical conditions according to treating medical physician;
  • Medical history of auto-immune disease and on active treatment;
  • Pregnancy or breast feeding. A negative pregnancy test must be available for women of childbearing potential (i.e. premenopausal women with intact reproductive organs and women less than two years after menopause);
  • Irradical endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) of the primary tumor prior to start of neoadjuvant therapy according to the patient's medical history;
  • Received an investigational drug within 30 days prior to the tracer administration according to the patient's medical history;
  • History of infusion reactions to durvalumab or nivolumab or other monoclonal antibodies according to the patient's medical history;

Key Trial Info

Start Date :

December 15 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 30 2026

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT07196384

Start Date

December 15 2025

End Date

December 30 2026

Last Update

November 21 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Optical PD-1 and PD-L1 Imaging in Locally Advanced Esophageal Cancer Using Durvalumab-680LT and Nivolumab-800CW | DecenTrialz